CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 23 No. 12
 

Boswellia (Boswellia serrata)

Complementary Therapies, Herbs, and Other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | November 16, 2009
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Native to India, boswellia is used extensively in Ayurveda, the traditional medical system of India, to treat arthritis. Extracts from the gum resin of boswellia have been tested in clinical trials and found effective for asthma and ulcerative colitis. More research is needed to determine if boswellia can benefit those with osteoarthritis. Boswellic acid has been found to display antitumor activity in bladder, cervical, and other cancer cell lines as well as anti-inflammatory activity.

Although no adverse effects have been reported with use of boswellia, consequences of long-term use are not known. The notion that herbs are safe because they are natural is not necessarily correct, and herb-drug interactions remain a concern.

Because reliable information about dietary supplements and “alternative” cancer treatments was not readily available to oncologists who needed it to counsel their patients, the MSKCC Integrative Medicine Service developed and maintains the free “AboutHerbs” website (http://www.mskcc.org/AboutHerbs). This site contains two portals, one for oncology professionals and another for the public. Anyone may enter either portal at no cost. This continually updated site provides objective information about herbs and other botanicals, vitamins, other dietary supplements, and unproved cancer therapies.

TREATMENT: Boswellia (Boswellia serrata)

ALSO KNOWN AS: Indian Frankincense, Indian olibanum, Shallaki, Salai guggal

BACKGROUND: Boswellia is a genus of trees containing a fragrant resin, which has been used since antiquity for many medicinal purposes. The resin extract has been used traditionally to treat arthritis, ulcerative colitis, coughs, sores, snakebite, asthma, and to correct disorders of the digestive system. Its aromatic properties also have been known for millennia. The Biblical incense frankincense was extracted from the resin of the Boswellia sacra, obtained by tapping the trees. In modern times, Boswellic acid has been found to display antitumor activity in bladder, cervical, and other cancer cell lines as well as anti-inflammatory activity.

RESEARCH: Boswellic acid, the biologically active constituent of boswellia gum resin, is thought to contribute to its pharmacologic activities. In vitro and animal studies showed that boswellic acid has anti-­inflammatory[1] and ­anticancer properties.[2] The anti-inflammatory effects are due to noncompetitive inhibition of 5-lipoxygenase, the key enzyme in biosynthesis of leukotrienes that play a major role in inflammatory disease.[3]

Data from clinical trials indicate that boswellia reduced both dyspnea and the number of attacks in asthmatic patients.[4] It also helped control symptoms in patients with ulcerative colitis,[3] but may not be useful for those with collagenous colitis.[5]

An analysis of 15 systematic reviews indicated insufficient evidence of boswellia’s effectiveness in treating osteoarthritic pain.[6]

Further research is also warranted to determine efficacy in cancer.

ADVERSE EFFECTS: None reported to date.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES:
1. Dahmen U, Gu YL, Dirsch O, et al: Boswellic acid, a potent anti-inflammatory drug, inhibits rejection to the same extent as high dose steroids. Transplant Proc 33:539-541, 2001.
2. Frank MB, Yang Q, Osban J, et al: Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity. BMC Complement Altern Med 9:6, 2009.
3. Gupta I, Parihar A, Malhotra P, et al: Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 2:37-43, 1997.
4. Gupta I, Gupta V, Parihar A, et al: Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 3:511-514, 1998.
5. Chande N, MacDonald JK, McDonald JW: Interventions for treating microscopic colitis: A Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 104:235-241, 2009.
6. Chrubasik JE, Roufogalis BD, Chrubasik S: Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res 21:675-683, 2007.


 
RELATED CONTENT

The Key to Reducing Quackery Lies in Healing Patients and Treating Their Experience
ONCOLOGY,  August 20, 2012
Quackery, Placebos, and Other Thoughts: An Integrative Oncologist’s Perspective
ONCOLOGY,  August 20, 2012
Cancer Quackery: The Persistent Popularity of Useless, Irrational 'Alternative' Treatments
ONCOLOGY,  August 20, 2012
Integrative Medicine: Not Just Garnish
ONCOLOGY Nurse Edition,  May 9, 2012
Green Tea (Camellia sinensis)
ONCOLOGY,  December 31, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy